Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management.
- Author:
Pow-Li CHIA
1
;
David FOO
1
Author Information
- Publication Type:Journal Article
- Keywords: cardiac implantable electronic devices; cardiac resynchronisation therapy; heart failure; implantable cardioverter defibrillator
- MeSH: Asian Continental Ancestry Group; Cardiac Resynchronization Therapy; Cardiology; Clinical Trials as Topic; Death, Sudden, Cardiac; Defibrillators, Implantable; Heart Failure; diagnostic imaging; epidemiology; therapy; Humans; Practice Guidelines as Topic; Singapore; Ventricular Dysfunction, Left; therapy
- From:Singapore medical journal 2016;57(7):354-359
- CountrySingapore
- Language:English
- Abstract: Clinical trials have established the benefits of implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) in the treatment of heart failure patients. As adjuncts to guideline-directed medical therapy, ICDs confer mortality benefits from sudden cardiac arrest, while CRT reduces mortality, hospitalisation rates and improves functional capacity. This review discusses the use of ICDs and CRT devices in heart failure management, outlining the evidence supporting their use, indications and contraindications.
